Radhika Kainthla
Overview
Explore the profile of Radhika Kainthla including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
174
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu C, Ferguson C, Vaish M, Arbab M, Kainthla R, Kumar K, et al.
J Cancer Educ
. 2025 Jan;
PMID: 39747707
Few medical students are exposed to evidence-based, multidisciplinary oncology care, and few studies in oncology education reflect consolidated pre-clinical curricula. We developed a four-week curriculum, "Frontiers in Neoplasia," for fourth-year...
2.
von Itzstein M, Liu J, Mu-Mosley H, Fattah F, Park J, Sorelle J, et al.
JTO Clin Res Rep
. 2024 Dec;
6(1):100751.
PMID: 39619775
Introduction: Racial and ethnic disparities in the presentation and outcomes of lung cancer are widely known. To evaluate potential factors contributing to these observations, we measured systemic immune parameters in...
3.
von Itzstein M, Liu J, Mu-Mosley H, Fattah F, Park J, Sorelle J, et al.
bioRxiv
. 2024 Jun;
PMID: 38915535
Introduction: Racial and ethnic disparities in the presentation and outcomes of lung cancer are widely known. To evaluate potential factors contributing to these observations, we measured systemic immune parameters in...
4.
Dong S, Premnath N, Sadeghi N, Kainthla R, Chung S, Collins R, et al.
Leuk Res
. 2024 Apr;
141:107503.
PMID: 38676993
Despite recent therapeutic advances, ethnic minorities in the U.S. continue to have disproportionately poor outcomes in many hematologic malignancies including AML. We identified 162 adult AML patients treated at a...
5.
Hsiehchen D, Beg M, Kainthla R, Lohrey J, Kazmi S, Khosama L, et al.
Nat Commun
. 2024 Mar;
15(1):2178.
PMID: 38467639
Immune checkpoint inhibitors targeting PD-1/L1 have modest efficacy in hepatocellular carcinoma as single agents. Targeting membranous phosphatidylserine may induce pro-inflammatory and -immune stimulating effects that enhance immunotherapy activity. This hypothesis...
6.
Lopez M, Kainthla R, Lazarte S, Chen W, Nijhawan A, Knights S
Eur J Haematol
. 2023 Dec;
112(5):723-730.
PMID: 38155405
Objective: To describe cases of Kaposi's sarcoma-associated herpesvirus (KSHV)-associated multicentric Castleman's disease (MCD) and primary effusion lymphoma (PEL) in patients with HIV from a large, safety-net hospital system in Dallas,...
7.
8.
Reddy S, Goksu S, Sanford N, Kainthla R, Hsiehchen D, Sanjeevaiah A, et al.
Cancer Med
. 2023 May;
12(13):14094-14103.
PMID: 37212509
Background: While the incidence of cholangiocarcinoma is rising, little is known about young-onset disease. We compared clinical characteristics and outcomes between patients with young-onset cholangiocarcinoma, diagnosed between the ages of...
9.
Knights S, Salyards M, Kendall N, Lazarte S, Kainthla R, Miley W, et al.
Open Forum Infect Dis
. 2023 Apr;
10(4):ofad160.
PMID: 37096147
Background: Disparities in mortality in human immunodeficiency virus (HIV)-associated Kaposi sarcoma have been described, particularly in Black men in the southern United States. It is unclear if there are racial/ethnic...
10.